Cell type-specific lipid storage changes in Parkinson’s disease patient brains are recapitulated by experimental glycolipid disturbance

Neurons are dependent on proper trafficking of lipids to neighboring glia for lipid exchange and disposal of potentially lipotoxic metabolites, producing distinct lipid distribution profiles among various cell types of the central nervous system. Little is known of the cellular distribution of neutr...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 117; no. 44; pp. 27646 - 27654
Main Authors Brekk, Oeystein Roed, Honey, Jonathan R., Lee, Seungil, Hallett, Penelope J., Isacson, Ole
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 03.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Neurons are dependent on proper trafficking of lipids to neighboring glia for lipid exchange and disposal of potentially lipotoxic metabolites, producing distinct lipid distribution profiles among various cell types of the central nervous system. Little is known of the cellular distribution of neutral lipids in the substantia nigra (SN) of Parkinson’s disease (PD) patients and its relationship to inflammatory signaling. This study aimed to determine human PD SN neutral lipid content and distribution in dopaminergic neurons, astrocytes, and microglia relative to age-matched healthy subject controls. The results show that while total neutral lipid content was unchanged relative to age-matched controls, the levels of whole SN triglycerides were correlated with inflammationattenuating glycoprotein non-metastatic melanoma protein B (GPNMB) signaling in human PD SN. Histological localization of neutral lipids using a fluorescent probe (BODIPY) revealed that dopaminergic neurons and midbrain microglia significantly accumulated intracellular lipids in PD SN, while adjacent astrocytes had a reduced lipid load overall. This pattern was recapitulated by experimental in vivo inhibition of glucocerebrosidase activity in mice. Agents or therapies that restore lipid homeostasis among neurons, astrocytes, and microglia could potentially correct PD pathogenesis and disease progression.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Author contributions: O.R.B., P.J.H., and O.I. designed research; O.R.B., J.R.H., and S.L. performed research; O.R.B., J.R.H., S.L., P.J.H., and O.I. analyzed data; and O.R.B., S.L., P.J.H., and O.I. wrote the paper.
2Present address: School of Clinical Medicine, Addenbrooke’s Hospital/University of Cambridge, Cambridge, CB2 0QQ Cambridgeshire, UK.
Edited by Solomon H. Snyder, Johns Hopkins University School of Medicine, Baltimore, MD, and approved September 2, 2020 (received for review February 17, 2020)
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.2003021117